StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-27 | $0.07 | $0.09 | +31.48% | 0.2M |
| 05-28 | $0.07 | $0.08 | +11.75% | 0.1M |
| 05-29 | $0.07 | $0.08 | +14.14% | 0.0M |
| 06-01 | $0.07 | $0.07 | -4.07% | 0.0M |
| 06-02 | $0.07 | $0.07 | -1.45% | 0.0M |
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Annual 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $1.15M | $708.00K | $2.20M | $1.44M |
Operating Income | $-1.06M | $-379.00K | $-2.27M | $-1.94M |
Net Income | $-1.25M | $-464.00K | $-2.40M | $-2.07M |
EPS (Diluted) | $-0.01 | $0.00 | $-0.02 | $-0.02 |
Total Assets | $788.00K | $1.19M | $1.06M | $1.06M |
Total Liabilities | $7.06M | $6.73M | $6.17M | $5.87M |
Cash & Equivalents | $198.00K | $434.00K | $334.00K | $540.00K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 111.89M | 111.89M | 111.89M | 111.86M |
No sell-side coverage available for PURE yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
PURE BIOSCIENCE